Table 1.

Participants baseline characteristics

Demographic characteristics		Groups		P-value
		Dienogest (n = 52)	GnRH agonist (n = 52)
BMI (kg/m2)*		24.90 (28.36–23.11)	23.59 (26.53–19.95)	0.14
Age (yr)**		35.00 (38–32)	32.00 (35–30)	0.06
Endometrioma localization***
	Bilateral	5 (10.8)	11 (22.4)	0.0649
	Right unilateral	7 (15.2)	2 (4)
	Left unilateral	4 (8.6)	7 (14.2)
USL involvement***
	Yes	29 (55.7)	38 (73.07)	0.0653
	No	23 (44.2)	14 (26.92)
Rectovaginal septal endometriosis***
	Yes	27 (51.9)	30 (58.8)	0.5539
	No	25 (48)	21 (41.1)
*Data presented as median (IQR), t test. **Data presented as median (IQR), Mann–Whitney test. ***Data presented as n (%), Chi-square test. GnRH: Gonadotropin-releasing hormone agonist, BMI: Body mass index, USL: Uterosacral ligament